title: Selective, orally active 5-HT1D receptor agonists as potential antimigraine agents.
authors.affiliation: Chemistry Department, Merck, Sharp and Dohme Research Laboratories, Harlow, Essex, U.K.
authors.forename: A M
authors.initials: AM
authors.lastname: MacLeod
authors.forename: L J
authors.initials: LJ
authors.lastname: Street
authors.forename: A J
authors.initials: AJ
authors.lastname: Reeve
authors.forename: R A
authors.initials: RA
authors.lastname: Jelley
authors.forename: F
authors.initials: F
authors.lastname: Sternfeld
authors.forename: M S
authors.initials: MS
authors.lastname: Beer
authors.forename: J A
authors.initials: JA
authors.lastname: Stanton
authors.forename: A P
authors.initials: AP
authors.lastname: Watt
authors.forename: D
authors.initials: D
authors.lastname: Rathbone
authors.forename: V G
authors.initials: VG
authors.lastname: Matassa
mesh_terms: D000284:Administration, Oral; D000818:Animals; D001682:Biological Availability; D008881:Migraine Disorders / Q000188:drug therapy*; D044346:Receptor, Serotonin, 5-HT1D; D011985:Receptors, Serotonin / Q000187:drug effects*; D017366:Serotonin Receptor Agonists / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D013045:Species Specificity
chemical_list: D044346:Receptor, Serotonin, 5-HT1D; D011985:Receptors, Serotonin; D017366:Serotonin Receptor Agonists